- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05913635
Effects of Time-Restricted Fasting on the Postprandial Glycemic Responses
June 21, 2023 updated by: Yuwei Liu, Fudan University
Effects of Time-Restricted Fasting on the Postprandial Glycemic Responses in Chinese Adults: A Randomized Crossover Study
The goal of this clinical trial is to investigate whether fasting timing has a significant effect on postprandial glycemic responses in healthy adults. The main questions it aims to answer are:
- Whether fasting timing has a significant effect on postprandial insulin actions and plasma glucose concentration.
- Whether fasting timing could modulate the glycemic metabolome and circadian rhythms in healthy individuals.
Participants will get the two interventions:
No-dinner: breakfast at 7.30 a.m., lunch at 1.00 p.m. and no dinner; No-breakfast: no breakfast, lunch at 1.00 p.m. and dinner at 8.00 p.m.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
A randomized, crossover study design is used with 2 intervention days and a 6-day washout period, to evaluate the effects of early and late fasting on postprandial glucose responses in healthy adults.
Randomization was performed by the Fudan staff with a block size of 2 using a balanced design using computer-executed software.
The primary endpoint is the fasting and postprandial blood glucose, insulin, and continuous glucose monitoring after fasting.
Secondary endpoints include postprandial blood lipids, clock gene expressions in peripheral blood cells, and non-targeted postprandial plasma metabolome.
The 2 intervention days include a no-breakfast day and a no-dinner day.
The diets before, during, and after the intervention day was designed according to Dietary Guidelines for Chinese Residents (2022), and the energy distribution of three meals is 1:1:1, with the energy percentage of carbohydrate, protein, and fat being 55%, 15%, and 30%, respectively.
The time of breakfast, lunch, and dinner is 7.30 a.m., 1.00 p.m., and 8.00 p.m., respectively.
All participants are instructed to follow their natural dietary plans in the wash-out period, and the food intakes and sleep circle were recorded by a modified food frequency questionnaire (FFQ).
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Shanghai Institute of Planned Parenthood Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Both men and women are eligible.
- Age: 18-40 years old.
- Healthy adults: no history of diabetes mellitus, no use of hypoglycemic drugs, no insulin injection.
- All participants have a good sleep circle, with no somnipathy.
Exclusion Criteria:
- Severe mental illness or other major medical comorbidities and autoimmune diseases (e.g., chronic renal failure, cardiovascular diseases, or cancer)
- Skipping breakfast or dinner more than 10 times within 6 months.
- Following a special diet, currently on weight loss medication, using sleeping medications.
- Pregnancy or to be pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: No-breakfast
One-day meal plan with no breakfast.
The dietary plan has been developed according to the Dietary Guidelines for Chinese Residents (2022), and the energy distribution of the two meals (lunch and dinner) is 1:1, with the energy percentage of carbohydrates, proteins, and fats being 55%, 15%, and 30%, respectively.
The total daily calorie intake has been calculated based on the gender difference of the participants.
Since the recommended daily calorie intake for males is 2000 kcal while for females it is 1600 kcal, each meal for males is designed to provide 667 kcal calories, comprising 92g carbohydrates, 22g fat, and 25g protein; each meal for females is designed to provide 533 kcal calories, comprising 73g carbohydrates, 18g fat, and 20g protein.
The carbohydrates are sourced from buckwheat flour and mixed grain rice, which create similar glycemic indexes for each meal.
Additionally, the one-day meal for both males and females includes 450g of vegetables and 320g of fruits.
|
The day before intervention day, all participants will be provided with 3 nutritionally balanced meals which are designed by the investigators.
On the no-breakfast intervention day, participants are instructed to fast and only be allowed to consume water until 1.00 p.m. and consume the above-designed lunch and dinner at 1.00 p.m. and 8.00 p.m. Additionally, all participants are informed that they are only allowed to consume water between meals and before receiving breakfast at 7.30 a.m. the following day.
|
Experimental: No-dinner
One-day meal plan with no dinner.
The dietary plan has been developed according to the Dietary Guidelines for Chinese Residents (2022), and the energy distribution of the two meals (breakfast and lunch) is 1:1, with the energy percentage of carbohydrates, proteins, and fats being 55%, 15%, and 30%, respectively.
The total daily calorie intake has been calculated based on the gender difference of the participants.
Since the recommended daily calorie intake for males is 2000 kcal while for females it is 1600 kcal, each meal for males is designed to provide 667 kcal calories, comprising 92g carbohydrates, 22g fat, and 25g protein; each meal for females is designed to provide 533 kcal calories, comprising 73g carbohydrates, 18g fat, and 20g protein.
The carbohydrates are sourced from buckwheat flour and mixed grain rice, which create similar glycemic indexes for each meal.
Additionally, the one-day meal for both males and females includes 450g of vegetables and 320g of fruits.
|
The day before intervention day, all participants will be provided with 3 nutritionally balanced meals which are designed by the investigators.
On the no-dinner intervention day, participants are instructed to consume the above-designed breakfast and lunch at 7.30 a.m. and 1.00 p.m., and no dinner.
Additionally, all participants are informed that they are only allowed to consume water between meals and before receiving breakfast at 7.30 a.m. on the following day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from fasting to postprandial postprandial blood glucose
Time Frame: Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
The primary endpoint is fasting and postprandial blood glucose with hexokinase tests.
|
Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Change from fasting to postprandial insulin
Time Frame: Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Fasting and postprandial insulin will be tested by ELISA KIT.
|
Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Results of continuous glucose monitoring
Time Frame: From the day before the first intervention day and the wash-out period till the day after the second intervention day (10 days in total)
|
Continuous glucose will be monitored by Abott glucose monitor.
|
From the day before the first intervention day and the wash-out period till the day after the second intervention day (10 days in total)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from fasting to postprandial blood lipids
Time Frame: Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Fasting and postprandial total-, HDL-, LDL-cholesterol, triglyceride will be tested.
|
Blood samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Analyzes of clock gene expression in peripheral blood cells (PBC)
Time Frame: PBC samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Clock gene expression in PBC will be evaluated by RT-PCR.
|
PBC samples collected before and after 2 hours at lunch on the no-breakfast day; blood samples collected before and after 2 hours at next day breakfast on the no-dinner day
|
Analyzes of postprandial plasma metabolome
Time Frame: Blood samples collected at 2 hours after each meal
|
Non-targeted plasma metabolites will be tested by LC-MS-MS after 2 hours of each meal.
|
Blood samples collected at 2 hours after each meal
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yuwei Liu, PhD, Fudan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nas A, Mirza N, Hagele F, Kahlhofer J, Keller J, Rising R, Kufer TA, Bosy-Westphal A. Impact of breakfast skipping compared with dinner skipping on regulation of energy balance and metabolic risk. Am J Clin Nutr. 2017 Jun;105(6):1351-1361. doi: 10.3945/ajcn.116.151332. Epub 2017 May 10.
- Jakubowicz D, Wainstein J, Landau Z, Raz I, Ahren B, Chapnik N, Ganz T, Menaged M, Barnea M, Bar-Dayan Y, Froy O. Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial. Diabetes Care. 2017 Nov;40(11):1573-1579. doi: 10.2337/dc16-2753. Epub 2017 Aug 22.
- Ogata H, Kayaba M, Tanaka Y, Yajima K, Iwayama K, Ando A, Park I, Kiyono K, Omi N, Satoh M, Tokuyama K. Effect of skipping breakfast for 6 days on energy metabolism and diurnal rhythm of blood glucose in young healthy Japanese males. Am J Clin Nutr. 2019 Jul 1;110(1):41-52. doi: 10.1093/ajcn/nqy346.
- Garaulet M, Lopez-Minguez J, Dashti HS, Vetter C, Hernandez-Martinez AM, Perez-Ayala M, Baraza JC, Wang W, Florez JC, Scheer FAJL, Saxena R. Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial. Diabetes Care. 2022 Mar 1;45(3):512-519. doi: 10.2337/dc21-1314.
- Lopez-Minguez J, Saxena R, Bandin C, Scheer FA, Garaulet M. Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study. Clin Nutr. 2018 Aug;37(4):1133-1140. doi: 10.1016/j.clnu.2017.04.003. Epub 2017 Apr 10.
Helpful Links
- Impact of breakfast skipping compared with dinner skipping on regulation of energy balance and metabolic risk
- Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial
- Effect of skipping breakfast for 6 days on energy metabolism and diurnal rhythm of blood glucose in young healthy Japanese males
- Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial.
- Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2022
Primary Completion (Actual)
December 25, 2022
Study Completion (Estimated)
December 31, 2023
Study Registration Dates
First Submitted
June 11, 2023
First Submitted That Met QC Criteria
June 21, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 21PJD005
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Consumption of lunch and dinner, with no breakfast
-
Clinical Nutrition Research Centre, SingaporeCompletedType 2 Diabetes, Obesity, Prediabetes
-
Université de SherbrookeCompleted
-
University of AarhusArla FoodsRecruitingPostprandial Lipid MetabolismDenmark
-
Rio de Janeiro State UniversityConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
Centre de Recherche Médicale de LambarénéMerck Sharp & Dohme LLCCompleted
-
USDA, Western Human Nutrition Research CenterU.S. Highbush Blueberry CouncilCompletedInflammationUnited States
-
ANTONIOS KOUTELIDAKISDemocritus University of Thrace; University of IoanninaEnrolling by invitation
-
a2 Milk Company Ltd.CompletedLactose Intolerance
-
Pennington Biomedical Research CenterRecruitingIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States